>> Download Survival Reports <<

>> First report demonstrating the safety and immunogenicity of the SARS-COV-2 BNT162b1 mRNA vaccine in younger and older Chinese adults: a randomized, placebo-controlled, observer-blind Phase I study << (from: researchsquare.com)

Published 2 months ago